GoldenGolden
Advanced Search
Evolve Biosystems

Evolve Biosystems

Evolve Biosystems is a biotechnology company founded in 2012.

Evolve BioSystems is a spin-out from the Foods For Health Institute (FFHI) at the University of California, Davis. It is a developer of microbiome-based products engineered to restore and maintain the gut microbiome. The company's platform focuses on human gut dysbiosis and various animal species.

Timeline

June 12, 2018
$40m series C announced

Funding was led by Bill & Melinda Gates Foundation and Li Ka Shing Foundation

May 30, 2017
$20m series B announced

Funding was led by Spruce Capital Partners/MLS. Other investors include Horizons Ventures, Tate & Lyle Ventures, Bow Capital and Acre Venture Partners.

August 31, 2015
$9m series A announced

Funding rounds

Patents

Products

People

Name
Role
LinkedIn

David Kyle

CEO

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Evolve BioSystems
February 8, 2021
www.prnewswire.com:443
/PRNewswire/ -- Evolve BioSystems announced today that it completed a substantial first close in a $55 million Series D round of funding, led by Cargill, the...
Evolve BioSystems
December 7, 2020
www.prnewswire.com:443
/PRNewswire/ -- The Regents of the University of California and Evolve BioSystems are pleased to announce that an Illinois federal judge has recently denied a...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.